author-photo

Scott A. Reisman

Reata Pharmaceuticals

17

Papers

457

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates

2019 Drug Design Development and Therapy
Show All
- Source
- Cite
- Save
Citations (17)
RTA 1701 is an oral RORγt inhibitor that suppresses the IL-17A response in non-human primates

2018 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (1)
The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling

2017 Free Radical Biology and Medicine
Show All
- Source
- Cite
- Save
Citations (24)
Abstract 15540: NRF2 Upregulation Attenuates Post-Infarct Ventricular Remodeling by Modifying Redox Signalling

2016 Circulation
Show All
- Source
- Cite
- Save
Citations (1)
Topical application of RTA 408 lotion activates Nrf2 in human skin and is well- tolerated by healthy human volunteers

2015 BMC Dermatology
Show All
- Source
- Cite
- Save
Citations (21)
Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skin.

2014 Archives of Dermatological Research
Show All
- Source
- Cite
- Save
Citations (33)
Contents Vol. 39, 2014

2014 American Journal of Nephrology
Show All
- Source
- Cite
- Save
Citations (0)
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease

2014 Xenobiotica
Show All
- Source
- Cite
- Save
Citations (56)
Topical Application of the Synthetic Triterpenoid RTA 408 Protects Mice from Radiation-Induced Dermatitis

2014 Radiation Research
Show All
- Source
- Cite
- Save
Citations (41)
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease $

2013 Redox biology
Show All
- Source
- Cite
- Save
Citations (35)